Alpha Tau Medical (DRTS) Interest & Investment Income (2021 - 2026)
Alpha Tau Medical (DRTS) posted Interest & Investment Income of $9.6 million for Q1 2026, up 1445.95% sequentially from -$716000.0 in Q1 2025, and up 1445.95% YoY from $623370.9 in Q1 2025.
Alpha Tau Medical (DRTS) Interest & Investment Income (2021 - 2026) Analysis & Trends
Alpha Tau Medical has reported Interest & Investment Income for 5 years, with the latest figure at $9.6 million in Q1 2026.
- Quarterly Interest & Investment Income rose 1445.95% year-over-year to $9.6 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $8.9 million (up 267.01% YoY) and the FY2025 annual result came in at $218000.0, up 105.07% from the prior year.
- Interest & Investment Income improved to $9.6 million in Q1 2026 per DRTS's latest filing, from -$716000.0 in the prior quarter.
- Over five years, Interest & Investment Income peaked at $17.0 million in Q1 2022 and troughed at -$6.0 million in Q2 2022.
- A 4-year average of $1.3 million and a median of -$597000.0 in 2023 frame the typical range for Interest & Investment Income.
- The sharpest annual moves came in 2022 and 2026: Interest & Investment Income tumbled 3002.7% in 2022, then jumped 1445.95% in 2026.
- Over 4 years, Interest & Investment Income stood at -$4.6 million in 2022, then soared by 109.95% to $457000.0 in 2023, then tumbled by 256.67% to -$716000.0 in 2025, then surged by 1445.95% to $9.6 million in 2026.
- According to Business Quant data, Interest & Investment Income over the past three periods registered $9.6 million, -$716000.0, and $457000.0 for Q1 2026, Q1 2025, and Q2 2023 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int & Inv Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 120.60 Mn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | -48.00 Mn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 48.00 Mn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 35.58 Mn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 27.90 Mn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | - |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 5.13 Mn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 28.14 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 10.98 Mn |
| 10 | Alpha Tau Medical | 1.32 Bn | 1.32 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 9.64 Mn |
| Mar 31, 2025 | -716,000.00 |
| Jun 30, 2023 | 457,000.00 |
| Mar 31, 2023 | -478,000.00 |
| Dec 31, 2022 | -4.59 Mn |
| Sep 30, 2022 | -4.74 Mn |
| Jun 30, 2022 | -6.02 Mn |
| Mar 31, 2022 | 16.96 Mn |
| Dec 31, 2021 | -148,000.00 |
| Sep 30, 2021 | 1.17 Mn |
| Jun 30, 2021 | 3.49 Mn |